Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Colleen McIlvennan and Larry Allen.

 
Connection Strength
  
 
 
14.220
  
  1. McIlvennan CK, Urra M, Helmkamp L, Messenger JC, Raymer D, Ream KS, Oldemeyer JB, Ambardekar AV, Barnes K, Allen LA. Magnitude of troponin elevation in patients with biomarker evidence of myocardial injury: relative frequency and outcomes in a cohort study across a large healthcare system. BMC Cardiovasc Disord. 2023 03 24; 23(1):151.
    View in: PubMed
    Score: 0.886
  2. McIlvennan CK, Jones J, Makic M, Meek PM, Chaussee E, Thompson JS, Matlock DD, Allen LA. Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study. Circ Heart Fail. 2021 10; 14(10):e008243.
    View in: PubMed
    Score: 0.796
  3. Allen LA, McIlvennan CK. Mis-GUIDED-The Importance of Negative Trials of Health Care Delivery and Implementation Science. JAMA Cardiol. 2021 02 01; 6(2):135-136.
    View in: PubMed
    Score: 0.764
  4. McIlvennan CK, Benton EM, Allen LA. Educate, Engage, Empower: Leveraging Technology to Promote Learning in Patients Implanted With a Left Ventricular Assist Device and Their Caregivers. Circ Cardiovasc Qual Outcomes. 2019 10; 12(10):e006107.
    View in: PubMed
    Score: 0.698
  5. McIlvennan CK, Grady KL, Matlock DD, Helmkamp LJ, Abshire M, Allen LA. End of life for patients with left ventricular assist devices: Insights from INTERMACS. J Heart Lung Transplant. 2019 04; 38(4):374-381.
    View in: PubMed
    Score: 0.659
  6. McIlvennan CK, Matlock DD, Thompson JS, Dunlay SM, Blue L, LaRue SJ, Lewis EF, Patel CB, Fairclough DL, Leister EC, Swetz KM, Baldridge V, Walsh MN, Allen LA. Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial. JACC Heart Fail. 2018 11; 6(11):904-913.
    View in: PubMed
    Score: 0.651
  7. McIlvennan CK, Thompson JS, Matlock DD, Cleveland JC, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Walsh MN, Allen LA. A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for Advanced Heart Failure: DECIDE-LVAD: Rationale, Design, and Pilot Data. J Cardiovasc Nurs. 2016 Nov/Dec; 31(6):E8-E20.
    View in: PubMed
    Score: 0.569
  8. Allen LA, McIlvennan CK. Predicting in-hospital worsening heart failure at time of admission, but do we really need another heart failure risk model? Am Heart J. 2016 08; 178:188-9.
    View in: PubMed
    Score: 0.554
  9. McIlvennan CK, Allen LA. Palliative care in patients with heart failure. BMJ. 2016 Apr 14; 353:i1010.
    View in: PubMed
    Score: 0.548
  10. McIlvennan CK, Allen LA. Quality of Life After Left Ventricular Assist Device Implantation: In a World Full of Data, #Missingness. J Card Fail. 2016 05; 22(5):338-9.
    View in: PubMed
    Score: 0.540
  11. McIlvennan CK, Eapen ZJ, Allen LA. Hospital readmissions reduction program. Circulation. 2015 May 19; 131(20):1796-803.
    View in: PubMed
    Score: 0.514
  12. McIlvennan CK, Matlock DD, Narayan MP, Nowels C, Thompson JS, Cannon A, Bradley WJ, Allen LA. Perspectives from mechanical circulatory support coordinators on the pre-implantation decision process for destination therapy left ventricular assist devices. Heart Lung. 2015 May-Jun; 44(3):219-24.
    View in: PubMed
    Score: 0.506
  13. McIlvennan CK, Allen LA. Outcomes in acute heart failure: 30-day readmission versus death. Curr Heart Fail Rep. 2014 Dec; 11(4):445-52.
    View in: PubMed
    Score: 0.498
  14. McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail. 2014 Nov; 7(6):1003-13.
    View in: PubMed
    Score: 0.493
  15. McIlvennan CK, Allen LA. To DT or not to DT, that is the question: working toward a comprehensive, patient-centered perspective on left ventricular assist device for destination therapy. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):13-4.
    View in: PubMed
    Score: 0.469
  16. Pfahl J, Thompson JS, Matlock DD, Allen LA, Dionne-Odom JN, Bakitas MA, McIlvennan CK. ENABLE-LVAD: Development and Implementation of a Novel Training Program for Clinicians Supporting Family Caregivers of Patients With a Left Ventricular Assist Device. J Cardiovasc Nurs. 2024 Jul-Aug 01; 39(4):E136-E139.
    View in: PubMed
    Score: 0.232
  17. Swat SA, Helmkamp LJ, Tietbohl C, Thompson JS, Fitzgerald M, McIlvennan CK, Harger G, Ho PM, Ahmad FS, Ahmad T, Buttrick P, Allen LA. Clinical Inertia Among Outpatients With?Heart?Failure: Application of Treatment Nonintensification Taxonomy to?EPIC-HF Trial. JACC Heart Fail. 2023 11; 11(11):1579-1591.
    View in: PubMed
    Score: 0.228
  18. Haynes JE, Matlock DD, Thompson JS, Mosley BS, Fitzgerald MD, McIlvennan CK, Allen LA. "Would You Get a Destination Therapy Left Ventricular Assist Device?": Health Care Workers' Views on a Preference-Sensitive Decision. Circ Heart Fail. 2022 12; 15(12):e009626.
    View in: PubMed
    Score: 0.213
  19. Knoepke CE, Chaussee EL, Matlock DD, Thompson JS, McIlvennan CK, Ambardekar AV, Schaffer EM, Khazanie P, Scherer L, Arnold RM, Allen LA. Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial. Med Decis Making. 2022 04; 42(3):404-414.
    View in: PubMed
    Score: 0.197
  20. Flint K, Chaussee EL, Henderson K, Breathett K, Khazanie P, Thompson JS, Mcilvennan CK, Larue SJ, Matlock DD, Allen LA. Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device. J Card Fail. 2021 04; 27(4):497-500.
    View in: PubMed
    Score: 0.189
  21. Allen LA, Venechuk G, McIlvennan CK, Page RL, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial. Circulation. 2021 02 02; 143(5):427-437.
    View in: PubMed
    Score: 0.188
  22. Venechuk GE, Khazanie P, Page RL, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. Am Heart J. 2020 11; 229:144-155.
    View in: PubMed
    Score: 0.185
  23. Samsky MD, DeVore AD, McIlvennan CK, Granger CB, Granger BB, Hernandez AF, Felker GM, Fonarow GC, Albert NM, Pi?a IL, Lanfear D, Allen LA. Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey. Circ Heart Fail. 2020 09; 13(9):e007456.
    View in: PubMed
    Score: 0.184
  24. McIlvennan CK, Allen LA, Devore AD, Granger CB, Kaltenbach LA, Granger BB. Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey. J Card Fail. 2020 07; 26(7):635-636.
    View in: PubMed
    Score: 0.182
  25. Fendler TJ, McIlvennan CK, Matlock DD, Thompson JS, Chaussee EL, Dunlay SM, LaRue SJ, Raymer DS, Spertus JA, Lewis EF, Patel CB, Walsh MN, Allen LA. Exploring differences between patients who accept, decline, and are deemed ineligible for left ventricular assist device implantation as destination therapy. J Heart Lung Transplant. 2020 07; 39(7):721-724.
    View in: PubMed
    Score: 0.180
  26. Matlock DD, McIlvennan CK, Thompson JS, Morris MA, Venechuk G, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Chaussee EL, Glasgow RE, Walsh MN, Allen LA. Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial. Med Decis Making. 2020 04; 40(3):289-301.
    View in: PubMed
    Score: 0.180
  27. McIlvennan CK, Matlock DD, Allen LA, Thompson JS, Ranby KW, Sannes TS. Perceived Stress and Depressive Symptoms as Predictors of Decisional Conflict in Dyads Considering a Left Ventricular Assist Device. Circ Cardiovasc Qual Outcomes. 2020 03; 13(3):e006155.
    View in: PubMed
    Score: 0.179
  28. Thompson JS, Matlock DD, Morris MA, McIlvennan CK, Allen LA. Organic Dissemination and Real-World Implementation of Patient Decision Aids for Left Ventricular Assist Device. MDM Policy Pract. 2018 Jan-Jun; 3(1):2381468318767658.
    View in: PubMed
    Score: 0.157
  29. Allen LA, McIlvennan CK, Thompson JS, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Fairclough DL, Leister EC, Glasgow RE, Cleveland JC, Phillips C, Baldridge V, Walsh MN, Matlock DD. Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):520-529.
    View in: PubMed
    Score: 0.157
  30. Allen LA, Matlock DD, Shetterly SM, Xu S, Levy WC, Portalupi LB, McIlvennan CK, Gurwitz JH, Johnson ES, Smith DH, Magid DJ. Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure. JAMA Cardiol. 2017 04 01; 2(4):435-441.
    View in: PubMed
    Score: 0.146
  31. Narayan M, Jones J, Portalupi LB, McIlvennan CK, Matlock DD, Allen LA. Patient Perspectives on Communication of Individualized Survival Estimates in Heart Failure. J Card Fail. 2017 Apr; 23(4):272-277.
    View in: PubMed
    Score: 0.144
  32. McIlvennan CK, Wordingham SE, Allen LA, Matlock DD, Jones J, Dunlay SM, Swetz KM. Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians. J Card Fail. 2017 Sep; 23(9):708-712.
    View in: PubMed
    Score: 0.143
  33. Jurgens PT, Allen LA, Ambardekar AV, McIlvennan CK. Chronic Norovirus Infections in Cardiac Transplant Patients. Prog Transplant. 2017 03; 27(1):69-72.
    View in: PubMed
    Score: 0.143
  34. McIlvennan CK, Allen LA, Matlock DD. Caregiver Perspectives on End-of-Life Experiences of Patients With Left Ventricular Assist Devices-Reply. JAMA Intern Med. 2016 08 01; 176(8):1231-2.
    View in: PubMed
    Score: 0.140
  35. Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 08; 35(8):1045-8.
    View in: PubMed
    Score: 0.138
  36. McIlvennan CK, Jones J, Allen LA, Swetz KM, Nowels C, Matlock DD. Bereaved Caregiver Perspectives on the End-of-Life Experience of Patients With a Left Ventricular Assist Device. JAMA Intern Med. 2016 Apr; 176(4):534-9.
    View in: PubMed
    Score: 0.137
  37. Thompson JS, Matlock DD, McIlvennan CK, Jenkins AR, Allen LA. Development of a Decision Aid for Patients?With Advanced Heart Failure Considering a Destination Therapy Left?Ventricular Assist Device. JACC Heart Fail. 2015 Dec; 3(12):965-76.
    View in: PubMed
    Score: 0.133
  38. Magid KH, Matlock DD, Thompson JS, McIlvennan CK, Allen LA. The influence of expected risks on decision making for destination therapy left ventricular assist device: An MTurk survey. J Heart Lung Transplant. 2015 Jul; 34(7):988-90.
    View in: PubMed
    Score: 0.127
  39. McIlvennan CK, Jones J, Allen LA, Lindenfeld J, Swetz KM, Nowels C, Matlock DD. Decision-making for destination therapy left ventricular assist devices: implications for caregivers. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):172-8.
    View in: PubMed
    Score: 0.127
  40. Iacovetto MC, Matlock DD, McIlvennan CK, Thompson JS, Bradley W, LaRue SJ, Allen LA. Educational resources for patients considering a left ventricular assist device: a cross-sectional review of internet, print, and multimedia materials. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):905-11.
    View in: PubMed
    Score: 0.123
  41. McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot". Circ Cardiovasc Qual Outcomes. 2014 May; 7(3):374-80.
    View in: PubMed
    Score: 0.120
  42. Kim JM, Maqsood MH, Makuvire T, McIlvennan CK, Thompson JS, Matlock DD, Allen LA, Warraich HJ. Gender-based differences in decision making, quality of life and survival among patients undergoing left ventricular assist device evaluation. PLoS One. 2023; 18(10):e0293121.
    View in: PubMed
    Score: 0.058
  43. Grady KL, Kallen MA, Beiser DG, Lindenfeld J, Teuteberg J, Allen LA, McIlvennan CK, Rich J, Yancy C, Lee CS, Denfeld QE, Kiernan M, Walsh MN, Adler E, Ruo B, Stehlik J, Kirklin JK, Bedjeti K, Cella D, Hahn EA. Novel measures to assess ventricular assist device patient-reported outcomes: Findings from the MCS A-QOL study. J Heart Lung Transplant. 2024 01; 43(1):36-50.
    View in: PubMed
    Score: 0.057
  44. Hahn EA, Allen LA, Lee CS, Denfeld QE, Stehlik J, Cella D, Lindenfeld J, Teuteberg JJ, McIlvennan CK, Kiernan MS, Beiser DG, Walsh MN, Adler ED, Ruo B, Kirklin JK, Klein L, Bedjeti K, Cummings PD, Burns JL, Vela AM, Grady KL. PROMIS: Physical, Mental and Social Health Outcomes Improve From Before to Early After LVAD Implant: Findings From the Mechanical Circulatory Support: Measures of Adjustment and Quality of Life (MCS A-QOL) Study. J Card Fail. 2023 10; 29(10):1398-1411.
    View in: PubMed
    Score: 0.055
  45. Hahn EA, Walsh MN, Allen LA, Lee CS, Denfeld QE, Teuteberg JJ, Beiser DG, McIlvennan CK, Lindenfeld J, Klein L, Adler ED, Stehlik J, Ruo B, Bedjeti K, Cummings PD, Vela AM, Grady KL. Validity of Patient-Reported Outcomes Measurement Information System Physical, Mental, and Social Health Measures After Left Ventricular Assist Device Implantation and Implications for Patient Care. Circ Cardiovasc Qual Outcomes. 2023 02; 16(2):e008690.
    View in: PubMed
    Score: 0.055
  46. Venechuk G, Allen LA, Thompson JS, Morris MA, Matlock DD, McIlvennan CK, Dickert NW, Tietbohl C. Trust and activation in defining patient-clinician interactions for chronic disease management. Patient Educ Couns. 2023 01; 106:113-119.
    View in: PubMed
    Score: 0.054
  47. Knoepke CE, Siry-Bove B, Mayton C, Latimer A, Hart J, Allen LA, Daugherty SL, McIlvennan CK, Matlock DD, Khazanie P. Variation in Left Ventricular Assist Device Postdischarge Caregiver Requirements: Results From a Mixed-Methods Study With Equity Implications. Circ Heart Fail. 2022 08; 15(8):e009583.
    View in: PubMed
    Score: 0.053
  48. Raymer DS, Allen LA, Chaussee EL, McIlvennan CK, Thompson JS, Fairclough DL, Dunlay SM, Matlock DD, Larue SJ. Health Literacy in Patients Considering a Left Ventricular Assist Device: Findings From the DECIDE-LVAD Trial. J Card Fail. 2022 08; 28(8):1318-1325.
    View in: PubMed
    Score: 0.052
  49. Scherer LD, Matlock DD, Allen LA, Knoepke CE, McIlvennan CK, Fitzgerald MD, Kini V, Tate CE, Lin G, Lum HD. Patient Roadmaps for Chronic Illness: Introducing a New Approach for Fostering Patient-Centered Care. MDM Policy Pract. 2021 Jan-Jun; 6(1):23814683211019947.
    View in: PubMed
    Score: 0.049
  50. Thompson JS, Fitzgerald MD, Allen LA, McIlvennan CK, Glasgow RE, Wynia M, Morris MA, Beilenson J, Gherst C, Matlock DD. Shared Decision-Making for Left Ventricular Assist Devices: Rationale and Design of a Nationwide Dissemination and Implementation Project. Circ Cardiovasc Qual Outcomes. 2021 02; 14(2):e007256.
    View in: PubMed
    Score: 0.048
  51. Bass ME, Kiser TH, Page RL, McIlvennan CK, Allen LA, Wright G, Shakowski C. Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus. J Thromb Thrombolysis. 2021 Aug; 52(2):517-522.
    View in: PubMed
    Score: 0.048
  52. Slavin SD, Allen LA, McIlvennan CK, Desai AS, Schaefer KG, Warraich HJ. Left Ventricular Assist Device Withdrawal: Ethical, Psychological, and Logistical Challenges. J Palliat Med. 2020 04; 23(4):456-458.
    View in: PubMed
    Score: 0.044
  53. Warraich HJ, Allen LA, Blue LJ, Chaussee EL, Thompson JS, McIlvennan CK, Flint KM, Matlock DD, Patel CB. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study. Am Heart J. 2019 07; 213:91-96.
    View in: PubMed
    Score: 0.042
  54. Nizamic T, Murad MH, Allen LA, McIlvennan CK, Wordingham SE, Matlock DD, Dunlay SM. Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2018 09; 6(9):757-767.
    View in: PubMed
    Score: 0.040
  55. Kwon R, Allen LA, Scherer LD, Thompson JS, Abdel-Maksoud MF, McIlvennan CK, Matlock DD. The Effect of Total Cost Information on Consumer Treatment Decisions: An Experimental Survey. Med Decis Making. 2018 07; 38(5):584-592.
    View in: PubMed
    Score: 0.040
  56. Magid M, McIlvennan CK, Jones J, Nowels CT, Allen LA, Thompson JS, Matlock D. Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis. Am Heart J. 2016 10; 180:64-73.
    View in: PubMed
    Score: 0.035
  57. Paine AM, Allen LA, Thompson JS, McIlvennan CK, Jenkins A, Hammes A, Kroehl M, Matlock DD. Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey. J Card Fail. 2016 Nov; 22(11):908-912.
    View in: PubMed
    Score: 0.034
  58. Magid M, Jones J, Allen LA, McIlvennan CK, Magid K, Thompson JS, Matlock DD. The Perceptions of Important Elements of Caregiving for a Left Ventricular Assist Device Patient: A Qualitative Meta-Synthesis. J Cardiovasc Nurs. 2016 May-Jun; 31(3):215-25.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)